| Pharmaceutical active ingredients: |
| Dibucaine Hydrochloride |
| Available forms, composition and doses of Proctocedyl: |
| Ointment; Topical; Dibucaine Hydrochloride 5 mg; Esculin 10 mg; Framycetin Sulfate 10 mg; Hydrocortisone 5 mg / gSuppositories; Rectal; Dibucaine Hydrochloride 5 mg; Esculin 10 mg; Framycetin Sulfate 10 mg; Hydrocortisone 5 mg |
| Proctocedyl medical category: |
| Human:Antipruritics and local anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C05AD04 - CinchocaineD04AB02 - CinchocaineN01BB06 - CinchocaineS01HA06 - Cinchocaine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |